Evidence map›Paper›PMID 39232673›Full record

ArticleBMC nephrology2024

Case report: membranoproliferative glomerulonephritis associated with Q fever causing chronic endocarditis.

Martin Loyen, Thorsten Wiech, Stefan Reuter, Gerold Thölking

Abstract readCase Reports
In one paragraph

Article in BMC nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Martin LoyenDepartment of Internal Medicine and Nephrology, Herz-Jesu-Krankenhaus Münster-Hiltrup, Münster-Hiltrup, Germany.
Thorsten WiechInstitute of Pathology, Nephropathology Section, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stefan ReuterDivision of General Internal Medicine, Nephrology and Rheumatology, Department of Medicine D, University Hospital of Münster, Münster, Germany.
Gerold ThölkingDepartment of Internal Medicine and Nephrology, Herz-Jesu-Krankenhaus Münster-Hiltrup, Münster-Hiltrup, Germany. Gerold.Thoelking@hjk-muenster.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMembranoproliferative glomerulonephritis is a rare entity which can be a result from autoimmune diseases, caused by various medications and infections. CASE PRESENTATION: We herein present the case of a 62-year-old male patient who presented with fatigue and was found to have severe anemia, impaired renal function, and nephrotic syndrome. A renal biopsy revealed membranoproliferative glomerulonephritis (MPGN) of the immune complex type with activation of the classical complement pathway. Further investigations led to the diagnosis of a chronic Coxiella burnetii-infection (Q fever), likely acquired during cycling trips in a region known for intensive sheep farming. Additionally, the patient was found to have a post endocarditic destructive bicuspid aortic valve caused by this pathogen. Treatment with hydroxychloroquine and doxycycline was administered for a duration of 24 months. The aortic valve was replaced successfully and the patient recovered completely.

conclusionsEarly detection and targeted treatment of this life-threatening disease is crucial for complete recovery of the patient.

Indexed as

Endocarditis, BacterialGlomerulonephritis, MembranoproliferativeQ FeverAnti-Bacterial AgentsAortic ValveBicuspid Aortic Valve DiseaseChronic DiseaseDoxycyclineHumansHydroxychloroquineMaleMiddle AgedAnti-Bacterial AgentsDoxycyclineHydroxychloroquineBicuspid aortic valveCase reportMembranoproliferative glomerulonephritisMPGNNephrotic syndromeQ fever

Identifiers

PMID39232673
PMCPMC11373086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.